A study of Medicare beneficiaries vaccinated against the flu last season—a severe one dominated by the H3N2 strain that hit seniors especially hard—found that the cell-based vaccine performed better than egg-based vaccines, but the difference wasn't enough to completely pin the low overall efficacy last season on egg adaptations in the vaccine strain.